Clinical Trial Update: Esmolol Effects on Heart and Inflammation in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating esmolol for effects on heart function and inflammation in septic shock; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Brevibloc (esmolol)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Septic Shock | Phase 2 | Status: UNKNOWN